Please assess the completion status of the following clinical trial:

Trial Title: Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~Both of following symptoms should be observed.~* Lower abdominal pain and/or lower abdominal tenderness.~* Hypochondrial pain and/or hypochondrial tenderness (tenderness of uterus or adnexa of uterus).~Exclusion Criteria:~Known or suspected hypersensitivity or intolerance to azithromycin, other macrolides, or ketolides.~Hepatic dysfunction (AST, ALT, total bilirubin \> 3 times institutional normal).

- Gender: FEMALE
- Minimum Age: 16 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Azithromycin switch therapy (switch from intravenous to oral). (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).